All VCT, EIS, SEIS, and Business Relief qualifying investments are high risk and are not suitable for most clients. They are illiquid investments and Investors’ capital is at risk.

Patient Capital Review read all about it…


Given the risks associated with Brexit and the potential loss of more than £1bn of SME funding from the European Investment Fund, the PCR is arguably one of the most important Reviews this century and has the potential to dramatically change the Economic fortunes of the UK for better or worse.

Over the past few weeks Dermot Campbell has contributed to the surrounding debate and submitted a formal response. Please click on the following links for Dermot’s insight and thoughts into the patient capital review:

How can we build a fit for purpose patient capital industry?

How patient capital is more than just tax avoidance